Adriamycin-inducible proteins associated with drug sensitivity in resistant immunoblastic B lymphoma cells.
We have previously established an immunoblastic B lymphoma cell line, designated HOB1. This cell line is hypersensitive to a wide spectrum of chemotherapeutic agents. Two co-regulated polypeptides around 64 kDa (termed p64) were induced 10-30-fold in response to adriamycin and some other drugs at the IC50 (the concentration inhibiting cell growth by 50%). These inducible proteins are localized as monomeric forms in the cytosolic fraction, with isoelectric points of pH = 6.2 (major protein) and pH = 7.0 (minor protein). An adriamycin-resistant cell line was established from HOB1 cells. The p64 inducibility was dramatically reduced in resistant HOB1 cells or unrelated cell lines which show phenotypic resistance to adriamycin toxicity. The loss of p64 inducibility in resistant cells is not due to a failure of cells to take up adriamycin since drug accumulation kinetics remained the same as in the parental cells.
Chao
C C
CC
Department of Biochemistry, Chang Gung Medical College, Taoyuan, Taiwan.
Yam
W C
WC
Chung
K C
KC
Ho
Y S
YS
D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001692:Biological Transport; D015153:Blotting, Western; D002458:Cell Fractionation; D003600:Cytosol / Q000737:chemistry; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000378:metabolism / Q000494:pharmacology*; D004351:Drug Resistance; D015972:Gene Expression Regulation, Neoplastic; D006367:HeLa Cells; D006801:Humans; D016393:Lymphoma, B-Cell / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000276:immunology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D004317:Doxorubicin